With so many forms of L-methylfolate available, we often get asked why the form in Enlyte is any different and how 7 mgs can be effective. Enlyte contains L-methylfolate magnesium, a form twice as soluble as the calcium form found in other folate preparations. The theme across all the ingredients in EnLyte is that less can be more. Click here to view solubility testing data.
Sunset, Louisiana (PRWEB) April 14, 2014
In March, the CDC reported a 30 percent rise in autism, now affecting one in 68 children. Prevention is key, and JayMac Pharmaceuticals, LLC is committed to educating on prenatal prevention with adequate supplementation.
Folate is crucial to the developing fetus, and supplementing with folic acid has been recommended for years to prevent neural tube defects. More recent research points to the link between folate and neurodegenerative disorders like autism. What we know now is that folic acid is not enough due to a common gene defect or “polymorphism” called MTHFR (Methylenetetrahydrofolate Reductase). MTHFR affects over 50 percent of the general population, and prevents folic acid from being converted to its usable form, L-methylfolate. The impact is significant. According to Dr. Lawrence Ginsberg, CEO, Red Oak Psychiatry: “Several studies have demonstrated a positive correlation between MTHFR polymorphisms and spontaneous abortions, neural tube defects, and neurodevelopmental disorders including autistic spectrum disorders.”
A guide on autism prevention by Dr. David Berger, MD, of Wholistic Pediatrics, reports: “Because women who have the abnormal MTHFR gene sequence may not be able to efficiently complete the conversion of folic acid to methylfolate, they may have issues if taking only folic acid. In such cases, I recommend that women not take folic acid but rather L-methylfolate or folinic acid or possibly a combination of both. These two forms bypass the faulty MTHFR enzyme and provide the fetus with activated folate.”
MTHFR is far too common to ignore, and taking a supplement that can get around it — and to the developing fetus — is crucial. Dr. Ginsberg: “Folic acid is inadequate; we cannot assume it will be adequately converted to L-methylfolate as we need this as a methyl group donor in the remethylation pathway.”
EnLyte with Delta Folate bypasses MTHFR with L-methylfolate magnesium, folinic acid, folic acid, and critical B-vitamin cofactors, and is pregnancy category A. Learn more at http://www.enlyterx.com.
Sunset, LA (PRWEB) June 10, 2014
JayMac Pharmaceuticals, LLC, the makers of EnLyte advanced generation folate therapy, are offering a podcast for health care professionals on the treatment of depression. This year, the Affordable Care Act will cover free screenings for depression, a condition often seen first in the primary care setting. It’s vital that these providers have the knowledge and tools essential to adequate diagnosis and treatment. To help with that effort, a new podcast will be available through the product website.
“Questions and Answers on Depression From a Primary Care Perspective” is a brief, educational podcast by Dr. Matthew Rosenberg, Medical Director of Mid-Michigan Health Centers in Jackson, MI. Dr. Rosenberg discusses common challenges faced when assessing this condition in the primary care office, and natural treatment options for patients. Click here to listen or download Dr. Rosenberg’s podcast.
Dr. Rosenberg is a Primary Care Physician who treats approximately 20 patients per week with depression.He states, “A nutrient approach to depression therapy offers the advantage of a lower side effect profile. The comprehensive nature of EnLyte targets several key nutrient deficiencies implicated in the etiology of depression. I believe that such an inclusive approach may result in much better response rates in patients who have this devastating disease.”
EnLyte contains Delta Folate and is used in the treatment of conditions related to folate deficiency. Visithttp://www.EnlyteRx.Com to learn more.
Orlando, Florida (PRWEB) September 11, 2014
JayMac Pharmaceuticals, LLC, Makers of EnLyte with Delta Folate, are participating in the Medical Academy of Pediatric Special Needs (MAPS) conference set to take place in Orlando September 11-13. MAPS brings together medical providers from around the nation for an in-depth curriculum aimed at educating on the treatment of children with autism spectrum disorder and other special needs conditions.
Families of children with these needs are increasingly seeking alternative treatment options. In fact, in a new study published in the Journal of Developmental and Behavioral Pediatrics, 40% of families with children who have autism or other developmental disorders said they use alternative medicine to treat their children, along with conventional therapies.
EnLyte with Delta Folate is an advanced generation prescription folate therapy designed to address common genetic polymorphisms such as the MTHFR defect, and to lower elevated homocysteine-two factors common in ASD. According to Dr. Lawrence Ginsberg, MD, of Red Oak Psychiatry, the implications of high homocysteine in ASD are decreased neurological functioning and neural degeneration during fetal development.
Factors like diet restrictions, absorption issues, and genetic factors-most notably the MTHFR defect-are unique and significant to Autism, being major players in decreasing the body’s ability to absorb B vitamins. Dr. Ginsberg has found an incidence of about 90% of the MTHFR defect in his practice in patients with autism spectrum disorders-meaning as much as a 70% reduction in their ability to use certain B vitamins.
The Autism Society has been in favor of supplements for years, Dr. Ginsberg states, and he finds many parents welcome an alternative to antipsychotics. Shelley Hendrix, parent of an 18 year old Autistic son: “It’s been my experience over the last 16 years that I’ve been in the Autism community that parents are experimenting with alternative treatments for their children. It’s nice to finally find a nutritional supplement regulated by the FDA that provides a uniform dose that avoids the common allergens such as gluten and dairy. It is also great to have a product like this that is prescribed by a physician and covered under most insurance and Medicaid. For families of children with autism who have been paying thousands of dollars out of pocket to provide nutritional supplements for their kids, this is very welcome news.”
EnLyte Is the first and only prescription folate therapy containing L-Methylfolate Magnesium, Folinic Acid, and Folic Acid, and all the necessary B-vitamin metabolites, in optimal doses, to completely address the remethylation and transsulfuration cycles, address genetic polymorphisms, and reduce high homocysteine. It is gluten free, casein free, dye free, and preservative free.
JayMac Pharmaceuticals, LLC is a Sunset, Louisiana-based pharmaceutical company gaining interest with the introduction of EnLyte into the psychotropic and psychiatric market.
Learn more at http://www.EnLyteRx.Com